Table 2.

In vitro cytotoxicity and inhibition of proliferation of cancer cell lines by T/Tn-specific lectins (ABL: Agaricus bisporus lectin; AAL: Agrocybe aegerita lectin; BfL: Bauhinia forficata lectin; GSA-IA4: Griffonia simplicifolia lectin; jacalin (Artocarpus integrifolia lectin); McL: Myrsine coriacea lectin; MCL: Momordica charantia lectin; ML-I, ML-II, ML-III: Mistletoe (Viscum album) lectins; PNA: peanut (Arachis hypogaea) agglutinin; ricin: Ricinus communis lectin; SBA: soybean (Glycine max) agglutinin; SRL: Sclerotium rolfsii lectin; riproximin (Ximenia americana).

Cancer Cell Line (H: Human, M: Mouse, R: Rat, Hamster: h)	Lectin	Toxicity	Proliferation Inhibition	Ref.
HT29 colon (H), MCF-7 breast (H)	ABL	-	+	[153]
HeLa (H), SW480 lymph node metastasis (H); SGC-7901, BGC-823	AAL	+ (M)	+	[35]
gastric cancer (H); MGC80-3 gastric adeno-carcinoma (H); HL-60
leukemia (H); S-180 sarcoma (M)
NCI-60 tumor cell line panel (H), LOX IMVI melanoma (H)	BfL	-	+	[46]
SK-MEL-28 melanoma (H), HT-144 melanoma (H), C32 melanoma	GSA-IA4	+	+	[54,154]
(H), LS174t, SW1116 colon cancer (H)
A431 epidermoid carcinoma (H); HT29 colorectal carcinoma (H)	Jacalin, PNA	+	+	[155,156]
JAr choriocarcinoma (H); H3B hepato-carcinoma (H); B16
melanoma (M)
EAC Ehrlich ascites carcinoma; A549 lung carcinoma (H); CNE-1	MCL	+	+	[157,158,159]
CNE-2 nasopharyngeal carcinoma (H)
BT20, BT549, MCF7, HS578T, HBL100, T47D breast cancer (H)	ML-I, -II, -III	+		[141,160]
SK-Hep-1, SK-Hep-3B hepatocarcinoma (H)
HT-29 colon (H)	McL	+	+	[64]
G-361 melanoma (H); HepG2 hepatoma (H); SKGIIIa cervical	Ricin	+	+	[161,162]
carcinoma (H)
Raji, Daudi lymphoma cell lines (H); JAr choriocarcinoma (H);	SBA	+	-	[155,163]
H3B hepato-carcinoma (H); B16 melanoma (M)
HT-29 colon (H)	SRL	+	+	[164]
MCF7, MDA-MB231 breast carcinoma (H); U87-MG brain tumor (H)	Riproximin	+	-	[85]
HEp2 larynx (H); NCI-H460 lung (H); HT29 colon (H); PC3
prostate (H); SKW3, K562, BV173 leukemia (H)